A BMJ study published in 2015 concluded that
High LDL-C is inversely associated with mortality in most people over 60 years. This finding is inconsistent with the cholesterol hypothesis.
You can find the BMJ study here:
Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review
While guidance for prescribing statins remains unchanged, more and more questions are being asked. The influence of Big Pharma on these decisions cannot be understated. Statin use is now so prevalent that a cottage industry has built up around studying their side effects. Dr. David Healy is a conscientious and responsible professional to follow if you are interested in the effects of Big Pharma on the FDA. Here is one of his excellent articles on the subject of randomized controlled trials and how they are run.
The Evidence that Counts for FDA
About Author
Bill Thompson, Jr. is a trial lawyer with extensive experience seeking compensation for serious harm caused by, among others, Hospitals, Physicians and other healthcare providers (Federal and State), Manufacturers of dangerous products and drugs (Ford, General Motors, Michelin, and pharmaceutical companies), Common Carriers (US Airways, Carnival Cruise Lines), Class Actions involving Data Breaches, product liability, Airline Crashes, and any other negligent act leading to harm for many. We have nationwide experience in State and Federal courts, traveling wherever significant cases merit. We are often asked to appear in cases by motion with local partners in places as varied as Michigan, Massachusetts, West Virginia, Pennsylvania, Georgia, and every jurisdiction in Florida.
